JAC Advance Access originally published online on January 28, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2004) 53, 518-521
© 2004 The British Society for Antimicrobial Chemotherapy
Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia
Departments of 1 Microbiology and 3 Urology, Kaohsiung Medical University, Kaohsiung; 2 Department of Food Science and Technology, Tajen Institute of Technology, Pingtung, Taiwan
Received 14 August 2003; returned 6 October 2003; revised 30 November 2003; accepted 1 December 2003
Objectives: The contribution of integrons and efflux pumps to multidrug resistance in Stenotrophomonas maltophilia was evaluated.
Materials and methods: Ninety-three S. maltophilia clinical isolates were studied. PCR and direct sequencing were used to detect the presence of integrons. Real-time PCR was performed to assess and quantify the expression of the Sme efflux pumps of S. maltophilia.
Results: Class 1 integrons were detected in 22% of clinical isolates and carried cassettes conferring resistance mainly to aminoglycosides and trimethoprim. The small multidrug resistance gene, smr, was found on class 1 integrons in six isolates. Thirty-one percent of the isolates overexpressed the smeDEF gene, as compared with a control strain, and 59% overexpressed the smeABC gene. Extrusion of ciprofloxacin and meropenem was specific to the SmeABC and SmeDEF pumps, respectively.
Conclusion: SmeABC and SmeDEF efflux pumps play important roles in resistance of S. maltophilia to ciprofloxacin and meropenem.
Keywords: real-time PCR, class 1 integrons, plasmids
* Corresponding author. Fax: +886-7-3218309; E-mail: m725006{at}kmu.edu.tw
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L.-L. Chang, H.-H. Lin, C.-Y. Chang, and P.-L. Lu Increased incidence of class 1 integrons in trimethoprim/sulfamethoxazole-resistant clinical isolates of Stenotrophomonas maltophilia J. Antimicrob. Chemother., May 1, 2007; 59(5): 1038 - 1039. [Full Text] [PDF] |
||||
![]() |
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF] |
||||
